Larimar Therapeutics, Inc is a biotechnology business based in the US. Larimar Therapeutics shares (LRMR) are listed on the NASDAQ and all prices are listed in US Dollars. Larimar Therapeutics employs 28 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Larimar Therapeutics
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – LRMR – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Larimar Therapeutics stock price (NASDAQ: LRMR)Use our graph to track the performance of LRMR stocks over time.
Larimar Therapeutics shares at a glance
|Latest market close||$8.31|
|52-week range||$7.80 - $25.87|
|50-day moving average||$9.30|
|200-day moving average||$14.22|
|Wall St. target price||$30.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-11.53|
Buy Larimar Therapeutics shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Larimar Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Larimar Therapeutics price performance over time
|1 week (2021-07-16)||N/A|
|1 month (2021-06-25)||-7.67%|
|3 months (2021-04-27)||-38.72%|
|6 months (2021-01-23)||N/A|
|1 year (2020-07-23)||N/A|
|2 years (2019-07-23)||N/A|
|3 years (2018-07-23)||N/A|
|5 years (2016-07-23)||N/A|
Larimar Therapeutics financials
|Gross profit TTM||$0|
|Return on assets TTM||-60.29%|
|Return on equity TTM||-118.2%|
|Market capitalisation||$176.9 million|
TTM: trailing 12 months
Shorting Larimar Therapeutics shares
There are currently 427,211 Larimar Therapeutics shares held short by investors – that's known as Larimar Therapeutics's "short interest". This figure is 3.3% up from 413,688 last month.
There are a few different ways that this level of interest in shorting Larimar Therapeutics shares can be evaluated.
Larimar Therapeutics's "short interest ratio" (SIR)
Larimar Therapeutics's "short interest ratio" (SIR) is the quantity of Larimar Therapeutics shares currently shorted divided by the average quantity of Larimar Therapeutics shares traded daily (recently around 219082.56410256). Larimar Therapeutics's SIR currently stands at 1.95. In other words for every 100,000 Larimar Therapeutics shares traded daily on the market, roughly 1950 shares are currently held short.
However Larimar Therapeutics's short interest can also be evaluated against the total number of Larimar Therapeutics shares, or, against the total number of tradable Larimar Therapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Larimar Therapeutics's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Larimar Therapeutics shares in existence, roughly 30 shares are currently held short) or 0.057% of the tradable shares (for every 100,000 tradable Larimar Therapeutics shares, roughly 57 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Larimar Therapeutics.
Find out more about how you can short Larimar Therapeutics stock.
Larimar Therapeutics share dividends
We're not expecting Larimar Therapeutics to pay a dividend over the next 12 months.
Have Larimar Therapeutics's shares ever split?
Larimar Therapeutics's shares were split on a 1:12 basis on 28 May 2020. So if you had owned 12 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Larimar Therapeutics shares – just the quantity. However, indirectly, the new 1100% higher share price could have impacted the market appetite for Larimar Therapeutics shares which in turn could have impacted Larimar Therapeutics's share price.
Larimar Therapeutics overview
Larimar Therapeutics, Inc. , a clinical-stage biotechnology company, focuses on developing treatments for rare diseases. The company's lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a rare and progressive genetic disease. Larimar Therapeutics, Inc. is headquartered in Bala Cynwyd, Pennsylvania. .
Stocks similar to Larimar Therapeutics
Larimar Therapeutics in the news
Larimar (LRMR) Upgraded to Buy: Here's Why
J. Alexander’s and Sykes Enterprises See Activist Action
Larimar Therapeutics to Present at the William Blair Biotech Focus Conference 2021
Frequently asked questionsWhat percentage of Larimar Therapeutics is owned by insiders or institutions?
Currently 2.454% of Larimar Therapeutics shares are held by insiders and 97.135% by institutions. How many people work for Larimar Therapeutics?
Latest data suggests 28 work at Larimar Therapeutics. When does the fiscal year end for Larimar Therapeutics?
Larimar Therapeutics's fiscal year ends in December. Where is Larimar Therapeutics based?
Larimar Therapeutics's address is: Three Bala Plaza East, Bala Cynwyd, PA, United States, 19004 What is Larimar Therapeutics's ISIN number?
Larimar Therapeutics's international securities identification number is: US5171251003
More guides on Finder
How to buy Clover Finance (CLV) in the US
This guide will show you step-by-step instructions on how to buy the Clover Finance (CLV) token as well as a list of exchanges you can trade it on.
How to buy AT-and-T (T) stock
Steps to owning and managing T, with 24-hour and historical pricing before you buy.
How to buy HNC Coin (HNC) in the US
This guide will show you step-by-step instructions on how to buy the Hellenic Coin (HNC) token as well as a list of exchanges you can trade it on.
How to buy Maro (MARO) in the US
This guide will show you step-by-step instructions on how to buy the Maro (MARO) token as well as a list of exchanges you can trade it on.
How to buy Ethernity Chain (ERN) in the US
This guide will show you step-by-step instructions on how to buy the Ethernity Chain (ERN) token as well as a list of exchanges you can trade it on.
How to buy Shopping.io (SPI) in the US
This guide will show you step-by-step instructions on how to buy the Shopping.io (SPI) token as well as a list of exchanges you can trade it on.
How to buy LUKSO Token (LYXE) in the US
This guide will show you step-by-step instructions on how to buy the LUKSO Token (LYXE) token as well as a list of exchanges you can trade it on.
How to buy KardiaChain (KAI) in the US
This guide will show you step-by-step instructions on how to buy the KardiaChain (KAI) token as well as a list of exchanges you can trade it on.
How to buy Neutrino USD (USDN) in the US
This guide will show you step-by-step instructions on how to buy the Neutrino USD (USDN) token as well as a list of exchanges you can trade it on.
How to buy Venus BTC (VBTC) in the US
This guide will show you step-by-step instructions on how to buy the Venus BTC (VBTC) token as well as a list of exchanges you can trade it on.
Ask an Expert